We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+14.54%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$30.8B
AUM Growth
+$518M
(+1.7%)
Cap. Flow
-$2.73B
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
1,143
New
66
Increased
528
Reduced
508
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$176M |
| 2 |
Credo Technology Group
CRDO
|
+$154M |
| 3 |
MACOM Technology Solutions
MTSI
|
+$71.5M |
| 4 |
Rambus
RMBS
|
+$69.5M |
| 5 |
NVMI
Nova
NVMI
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$386M |
| 2 |
NVIDIA
NVDA
|
+$300M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$272M |
| 4 |
Broadcom
AVGO
|
+$248M |
| 5 |
Qualcomm
QCOM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.44% |
| 2 | Financials | 9.98% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Keros Therapeutics
KROS
$199M
| $697K | ﹤0.01% |
44,066
-10,228
| -19% | -$151K |
|
852
Heritage Financial
HFWA
$1.22B
| $696K | ﹤0.01% |
28,780
-9,324
| -24% | -$226K |
|
853
Washington Trust Bancorp
WASH
$743M
| $694K | ﹤0.01% |
24,031
-1,679
| -7% | -$48.6K |
|
854
Loar Holdings
LOAR
$6.41B
| $690K | ﹤0.01% |
8,630
+1,599
| +23% | +$120K |
|
855
Lamb Weston
LW
$7.22B
| $690K | ﹤0.01% |
11,880
-86
| -0.7% | -$4.7K |
|
856
Dianthus Therapeutics
DNTH
$5.84B
| $682K | ﹤0.01% |
17,331
-11,191
| -39% | -$286K |
|
857
Vitesse Energy
VTS
$651M
| $675K | ﹤0.01% |
29,073
+3,198
| +12% | +$78.6K |
|
858
Arcturus Therapeutics
ARCT
$164M
| $664K | ﹤0.01% |
36,050
-1,596
| -4% | -$25.6K |
|
859
Financial Institutions
FISI
$816M
| $663K | ﹤0.01% |
24,373
+2,128
| +10% | +$56.8K |
|
860
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $661K | ﹤0.01% |
10,713
+5,026
| +88% | +$311K |
|
861
Amerant Bancorp
AMTB
$1.16B
| $656K | ﹤0.01% |
34,068
+2,469
| +8% | +$49.8K |
|
862
Vir Biotechnology
VIR
$1.46B
| $655K | ﹤0.01% |
114,785
-17,236
| -13% | -$88.1K |
|
863
Hanmi Financial
HAFC
$945M
| $655K | ﹤0.01% |
26,510
-377
| -1% | -$9.29K |
|
864
Molson Coors Class B
TAP
$7.79B
| $653K | ﹤0.01% |
14,435
-77
| -0.5% | -$3.8K |
|
|
UPB
865
Upstream Bio Inc
UPB
$343M
| $649K | ﹤0.01% |
+34,521
| New | +$536K |
|
866
Fox Class B
FOX
$21.8B
| $644K | ﹤0.01% |
11,245
+69
| +0.6% | +$3.64K |
|
|
BKV
867
BKV Corp
BKV
$2.68B
| $637K | ﹤0.01% |
+27,523
| New | +$600K |
|
868
Old Second Bancorp
OSBC
$1.29B
| $636K | ﹤0.01% |
36,771
+3,995
| +12% | +$71.9K |
|
869
Regenxbio
RGNX
$620M
| $636K | ﹤0.01% |
65,859
+5,204
| +9% | +$46K |
|
870
ArriVent BioPharma
AVBP
$1.39B
| $634K | ﹤0.01% |
34,361
+18,612
| +118% | +$366K |
|
|
HONE
871
DELISTED
HarborOne Bancorp
HONE
| $632K | ﹤0.01% |
46,470
+10,102
| +28% | +$126K |
|
872
Eastman Chemical
EMN
$8B
| $616K | ﹤0.01% |
9,777
| – | – |
|
873
Hormel Foods
HRL
$13.8B
| $614K | ﹤0.01% |
24,836
+133
| +0.5% | +$3.68K |
|
874
Mercantile Bank Corp
MBWM
$1.04B
| $603K | ﹤0.01% |
13,411
+4,985
| +59% | +$237K |
|
875
Univest Financial
UVSP
$1.22B
| $600K | ﹤0.01% |
19,999
+1,207
| +6% | +$37.1K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Rafferty Asset Management held 1,143 positions worth $30.8B, up 1.7% from $30.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management withdrew a net $2.73B in Q3 2025, closing 39 positions and reducing 508 holdings. Its most notable exit was Qorvo, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in Astera Labs worth $210M.
- Rafferty Asset Management's largest Q3 2025 buy was Astera Labs: 1,070,475 shares worth $210M.
- Rafferty Asset Management added most to Invesco QQQ Trust in Q3 2025, an estimated $42.9M increase.
- Rafferty Asset Management's biggest Q3 2025 reduction was Advanced Micro Devices, cutting an estimated $386M.
- Rafferty Asset Management fully exited Qorvo in Q3 2025, selling an estimated $103M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $30.8B portfolio in Q3 2025.
- Rafferty Asset Management opened 66 new positions and closed 39 in Q3 2025.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $30.8B.
Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.